Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SDD in ICU with high antibiotic resistance
NCT04839653Unknown
- Sponsor
- Medsi Clinical Hospital 1
- Start
- May 2021
- Primary completion
- Apr 2022
- Modality
- Nanoparticles, Implantable Devices, Transdermal Patches
- Countries
- 1
01
Overview
Open-label trial of polymyxin B, gentamicin, amphotericin B liposomal, vancomycin, cefotaxime and 1 more in ventilator-associated pneumonia (VAP) and bloodstream infection (BSI), sponsored by Medsi Clinical Hospital 1. Status: unknown.
02
Drugs
polymyxin Bgentamicinamphotericin B liposomalvancomycincefotaxime
03
Conditions
ventilator-associated pneumonia (VAP)bloodstream infection (BSI)
Beyond the preview
Go deeper on NCT04839653.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04839653.